Analysis of ecstasy in oral fluid by ion mobility spectrometry and infrared spectroscopy after liquid-liquid extraction

Journal of Chromatography A

Volumn 1384, Issue , 2015, Pages 1-8

  Armenta, Sergio ^a   Garrigues, Salvador ^a   de la Guardia, Miguel ^a   Brassier, Judit ^b   Alcalà, Manel ^b   Blanco, Marcelo ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Double confirmation; Ecstasy; Identification; Infrared spectroscopy; Ion mobility spectrometry

Indexed keywords

IDENTIFICATION (CONTROL SYSTEMS); INFRARED SPECTROSCOPY; IONS; LIQUIDS; SOLVENT EXTRACTION; SPACECRAFT INSTRUMENTS; SPECTROMETRY; SPECTRUM ANALYSIS; THERMAL DESORPTION;

DOUBLE CONFIRMATION; ECSTASY; ION MOBILITY SPECTRA; ION MOBILITY SPECTROMETRY; LIMIT OF DETECTION; LIQUID-LIQUID EXTRACTION; LIQUID-LIQUID MICROEXTRACTION; OPERATIONAL PROCEDURES;

ION MOBILITY SPECTROMETERS;

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ACETIC ACID; STREET DRUG;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DESORPTION; HUMAN; INFRARED SPECTROSCOPY; ION MOBILITY SPECTROMETRY; LIMIT OF DETECTION; LIQUID PHASE MICROEXTRACTION; METHODOLOGY; SALIVA ANALYSIS; ADULT; CHEMISTRY; FEMALE; INFRARED SPECTROPHOTOMETRY; LIQUID LIQUID EXTRACTION; MALE; PROCEDURES; SALIVA; STANDARDS; SUBSTANCE ABUSE;

ADULT; FEMALE; HUMANS; LIMIT OF DETECTION; LIQUID-LIQUID EXTRACTION; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; SALIVA; SPECTROPHOTOMETRY, INFRARED; STREET DRUGS; SUBSTANCE ABUSE DETECTION;

EID: 84922644753     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2015.01.036     Document Type: Article

References (41)

1. European Drug Report, Trends and Developments, European Monitoring Centre for Drugs and Drug Addiction, Portugal 2013, http://www.emcdda.europa.eu/.
2. EMCDDA and Europol EU Drug Markets Report. A Strategic Analysis 2013, European Monitoring Centre for Drugs and Drug Addiction and Europol, Lisbon/Hague. http://www.emcdda.europa.eu/publications/joint-publications/drugmarkets.
3. Gronholm M., Lillsunde P. A comparison between on-site immunoassay drug-testing devices and laboratory results. Forensic Sci. Int. 2001, 121:37-46.
4. Crouch D.J., Hersch R.K., Cook R.F., Frank J.F., Walsh J.M. A field evaluation of five on-site drug-testing devices. J. Anal. Toxicol. 2002, 26:493-499.
5. Cone E.J., Presley L., Lehrer M., Seiter W., Smith M., Kardos K.W., Fritch D., Salamone S., Niedbala R.S. Oral fluid testing for drugs of abuse: positive prevalence rates by intercept immunoassay screening and GC-MS-MS confirmation and suggested cut-off concentrations. J. Anal. Toxicol. 2002, 26:541-546.
6. Helmlin H.J., Bracher K., Bourquin D., Vonlanthen D., Brenneisen R., Styk L. Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS. J. Anal. Toxicol. 1996, 20:432-440.
7. Wong R.C., Tse H.Y. Drugs of Abuse: Body Fluid Testing 2005, Humana Press, Totowa.
8. Valcárcel M., Cárdenas S., Gallego M. Sample screening systems in analytical chemistry. Trend Anal. Chem. 1999, 18:685-694.
9. Eiceman G.A., Nazarov E.G., Stone J.A. Chemical standards in ion mobility spectrometry. Anal. Chim. Acta 2003, 493:185-194.
10. Keller T., Schneider A., Tutsch-Bauer E., Jaspers J., Aderjan R., Skopp G. Ion mobility spectrometry for the detection of drugs in cases of forensic and criminalistic relevance. Int. J. Ion Mobil. Spectrom. 1999, 2:22-34.
11. Miki A., Keller T., Regenscheit P., Dirnhofer R., Tatsuno M., Katagi M., Nishikawa M., Tsuchihashi H. Application of ion mobility spectrometry to the rapid screening of methylamphetamine incorporated in hair. J. Chromatogr. B: Biomed. Appl. 1997, 692:319-328.
12. Harrington P.D., Reese E.S., Rauch P.J., Hu L.J., Davis D.M. Interactive self-modeling mixture analysis of ion mobility spectra. Appl. Spectrosc. 1997, 51:808-816.
13. Lu Y., O'Donnell R.M., Harrington P.B. Detection of cocaine and its metabolites in urine using solid phase extraction-ion mobility spectrometry with alternating least squares. Forensic Sci. Int. 2009, 189:54-59.
14. Jafari M.T., Kamfirozi M., Jazan E., Ghoreishi S.M. Selective extraction and analysis of pioglitazone in cow plasma using a molecularly imprinted polymer combined with ESI ion mobility spectrometry. J. Sep. Sci. 2014, 37:573-579.
15. Li M., Zhang J., Jiang J., Zhang J., Gao J., Qiao X. Rapid, in situ detection of cocaine residues based on paper spray ionization coupled with ion mobility spectrometry. Analyst 2014, 139:1687-1691.
16. Ameli A., Kalhor H., Alizadeh N. Simultaneous analysis of non-steroidal anti-inflammatory drugs using electrochemically controlled solid-phase microextraction based on nanostructure molecularly imprinted polypyrrole film coupled to ion mobility spectrometry. J. Sep. Sci. 2013, 36:1797-1804.
17. Armenta S., Blanco M. Pros and cons of benzodiazepine screening in human saliva by ion mobility spectrometry. Anal. Bioanal. Chem. 2011, 401:1935-1948.
18. Midey A.J., Patel A., Moraff C., Krueger C.A., Wu C. Improved detection of drugs of abuse using high-performance ion mobility spectrometry with electrospray ionization (ESI-HPIMS) for urine matrices. Talanta 2013, 116:77-83.
19. Armenta S., de la Guardia M., Alcalà M., Blanco M. Noninvasive double confirmation of cocaine abuse. Anal. Chem. 2013, 85:11382-11390.
20. Bartick E.G. Applications of vibrational spectroscopy in criminal forensic analysis. Handbook of Vibrational Spectroscopy 2002, 2993-3004. John Wiley & Sons Ltd, Chichester. J.M. Chalmers, P.R. Griffiths (Eds.).
21. Koulis C.V., Hymes K.J., Rawlins J.L. A new infrared spectral library of controlled and noncontrolled drug standards using internal reflection spectroscopy. J. Forensic Sci. 2000, 45:876-881.
22. Bukowski E.J., Monti J.A. FTIR-ATR Spectroscopy for Identification of Illicit Drugs Seized from Clandestine Laboratories 2007, American Laboratory. http://www.americanlaboratory.com/914-Application-Notes/1449-FTIR-ATR-Spectroscopy-for-Identification-of-Illicit-Drugs-Seized-From-Clandestine-Laboratories/.
23. Gonzalvez A., Garrigues S., Armenta S., de la Guardia M. The ways to the trace level analysis in infrared spectroscopy. Anal. Methods (UK) 2011, 3:43-52.
24. Zhou Y.P., Xu L., Tang L.J., Jiang J.H., Shen G.L., Yu R.Q., Ozaki Y. Determination of glucose in plasma by dry film-based Fourier transformed-infrared spectroscopy coupled with boosting support vector regression. Anal. Sci. 2007, 23:793-798.
25. Scientific Working Group for the Analysis of Seized Drugs (SWGDRUG) Recommendations 2014, United States Department of Justice, Drug Enforcement Administration, http://www.swgdrug.org/Documents/SWGDRUG%20Recommendations%20Version%207-0.pdf (accessed December 2014).
26. Whatman Technical Note, PTFE Filters for Use in US EPA PM 2. 5 Ambient Air Monitoring 2014, http://www.whatman.com/References/PM25TechnicalNote.pdf (accessed May 2014).
27. Keller T., Miki A., Regenscheit P., Dirnhofer R., Schneider A., Tsuchihashi H. Detection of designer drugs in human hair by ion mobility spectrometry (IMS). Forensic Sci. Int. 1998, 94:55-63.
28. Siems W.F., Wu C., Tarver E.E., Hill H.H., Larsen P.R., McMinn D.G. Measuring the resolving power of ion mobility spectrometers. Anal. Chem. 1994, 66:4195-4201.
29. Humphrey S.P., Williamson R.T. A review of saliva: normal composition, flow, and function. J. Prosthet. Dent. 2001, 85:162-169.
30. Taylor Noggle F., DeRuiter J., Long M.J. Spectrophotometric and liquid chromatographic identification of 3,4-methylenedioxyphenylisopropylamine and its N-methyl and N-ethyl homologs. J. Assoc. Off. Anal. Chem. 1986, 69:681-686.
31. Baran O. Determination of Narcotic and Psychotropic Substances by using Infrared Spectroscopy 2005, (Master thesis), Middle East Technical University, Cyprus.
32. Lawrence A.H. Ion mobility spectrometry/mass spectrometry of some prescription and illicit drugs. Anal. Chem. 1986, 58:1269-1272.
33. Demoranville L.T., Verkouteren J.R. Measurement of drug facilitated sexual assault agents in simulated sweat by ion mobility spectrometry. Talanta 2013, 106:375-380.
34. Navarro M., Pichini S., Farré M., Ortuño J., Roset P.N., Segura J., de la Torre R. Usefulness of saliva for measurement of 3,4-methylenedioxymethamphetamine and its metabolites: correlation with plasma drug concentrations and effect of salivary pH. Clin. Chem. 2001, 47:1788-1795.
35. Eiceman G.A., Blyth D.A., Shoff D.B., Snyder A.P. Screening of solid commercial pharmaceuticals using ion mobility spectrometry. Anal. Chem. 1990, 62:1374-1379.
36. Verkouteren J.R., Staymates J.L. Reliability of ion mobility spectrometry for qualitative analysis of complex, multicomponent illicit drug samples. Forensic Sci. Int. 2011, 206:190-196.
37. Pichini S., Navarro M., Farre M., Ortuño J., Nolasc Roset P., Pacifici R., Zuccaro P., Segura J., de la Torre R. On-site testing of 3,4-methylenedioxymethamphetamine (Ecstasy) in saliva with Drugwipe and Drugread: a controlled study in recreational users. Clin. Chem. 2002, 48:174-176.
38. Parrott A.C., Lock J., Conner A.C., Kissling C., Thome J. Dance clubbing on MDMA and during abstinence from Ecstasy/MDMA: prospective neuroendocrine and psychobiological changes. Neuropsychobiology 2008, 57:165-180.
39. Samyn N., De Boeck G., Wood M., Lamers C., De Waard D., Brookhuis K., Verstraete A., Riedel W. Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions. Forensic Sci. Int. 2002, 128:90-97.
40. US National Highway Traffic Safety Administration Drugs and Human Performance Fact Sheets 2004, US, (accessed September 2014). http://www.nhtsa.gov/people/injury/research/job185drugs/methylenedioxymethamphetamine.htm.
41. Harris D.S., Baggott M., Mendelson J., Mendelson J.E., Jones R.T. Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl) 2002, 162:396-405.